Catalent
CTLT
#1602
Rank
C$15.00 B
Marketcap
$82.65
Share price
-0.85%
Change (1 day)
78.51%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.73

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.79. In 2022 the company made an earnings per share (EPS) of $3.16 a decrease over its 2021 EPS that were of $4.55.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.73-154.76%
2022$3.16-30.58%
2021$4.5579.67%
2020$2.53114.12%
2019$1.18-15%
2018$1.3975.44%
2017$0.79-22.97%
2016$1.03-59.56%
2015$2.55282.05%
2014$0.67-378.2%
2013-$0.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.10-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.04-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.96 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$8.89-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA